Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 207.67M P/E - EPS this Y - Ern Qtrly Grth -
Income -40.73M Forward P/E - EPS next Y - 50D Avg Chg -3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -
Dividend N/A Price/Book 6.43 EPS next 5Y - 52W High Chg -28.00%
Recommedations - Quick Ratio 1.17 Shares Outstanding 303.41M 52W Low Chg 36.00%
Insider Own 12.71% ROA -79.96% Shares Float 264.90M Beta 1.53
Inst Own 0.05% ROE -183.58% Shares Shorted/Prior -/- Price 0.68
Gross Margin - Profit Margin - Avg. Volume 14,206 Target Price -
Oper. Margin - Earnings Date Jun 12 Volume 1,800 Change 0.27%
About SERNOVA CORPORATION

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

SERNOVA CORPORATION News
11/27/23 Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for its Hemophilia A Program from FDA
10/30/23 Sernova Announces New Advancements of Conformal Coating Technology in Combination with the Cell Pouch System™ at the 2023 IPITA-IXA-CTRMS Joint Congress
10/27/23 Sernova Announces Positive Ongoing Interim Phase 1/2 Clinical Data for the Cell Pouch System™ for Type 1 Diabetes Trial at the 2023 IPITA, IXA, and CTRMS Joint Congress
10/11/23 Sernova to Provide Two Program Updates in Podium Presentations at 2023 IPITA Congress
09/29/23 Sernova Presents Compelling New Data on the Cell Pouch System™ as a Promising Treatment for Post-Operative Hypothyroidism at the 2023 American Thyroid Association Annual Meeting
09/14/23 Sernova Investor Conference Call Previously Scheduled for September 15 Now Rescheduled for September 22
09/13/23 Sernova to Host Investor Calls to Introduce Newly Appointed CEO and Provide Business Update
09/07/23 Sernova Provides Development Update on Proprietary Cellular Conformal Coating Technology in Combination with Cell Pouch Device
09/05/23 Sernova Corporation Announces the Appointment of Cynthia Pussinen as CEO
07/26/23 Sernova Expands Leadership Team with Appointment of Modestus Obochi, Ph.D., MBA, as Chief Business Officer
06/26/23 Sernova Announces Positive Updated Interim Phase 1/2 Clinical Data for the Cell Pouch System™ at American Diabetes Association 83rd Scientific Sessions
06/22/23 Sernova to Present Updated Interim Phase 1/2 Clinical Data on Cell Pouch System™ During Oral Presentation at American Diabetes Association 83rd Scientific Sessions
06/16/23 Sernova to Participate in Upcoming Truist Securities Cell Therapy Symposium
05/31/23 Sernova Announces Executive Alignment and Appoints New Board Chair
SEOVF Chatroom

User Image djahne Posted - 04/28/24

$SEOVF https://www.linkedin.com/posts/piotr-witkowski-bbb6b6b1_durability-of-insulin-independence-after-activity-7190086236609339392-VVdE

User Image ToRni27 Posted - 04/25/24

$SEOVF please do a 20:1 RS and start from the scratch on an Evotec phase 1/2 trial. Get listed on NASDAQ after R/S and do a funding of 250M us dollar. GL

User Image ToRni27 Posted - 04/25/24

$SEOVF Evotec is going under with this. Scammy former Evotec CEO bought this for 1.57 and 2.47 CAD right? Market manipulation at its best. Wondering if Evotec shareholders will go to court because of overpaying with their money into Sernova.

User Image ToRni27 Posted - 04/25/24

$SEOVF wondering that you still post bullish… the whole report shows the mess in this company. CFO issues, shareholder activist leaving board, Dr. PT gone, conformal coating not working, they have a hard time to get capital and so on.

User Image ToRni27 Posted - 04/25/24

$SEOVF they cancelled Conformal-Coating. Their fairy tale is over finally. That means a possible typ 2 diabetes market is gone + this will be in a niche position for typ 1 if ever. Their possible market is shrinking by a lot today. Only hard to treat patients are gonna use this cuz of side effects.

User Image djahne Posted - 04/25/24

$SEOVF https://ceo.ca/@thenewswire/sernova-provides-organizational-update

User Image ToRni27 Posted - 04/25/24

$SEOVF you ok Sernova?

User Image Dude1234 Posted - 1 month ago

$SEOVF Only small position here. Anyone know why we're up today. Love the tech, but not the shares out an financial situation. I know they have Hemophilia, Diabetes and there's been some recent buzz on thyroid stuff. Don't have time at moment to research, busy with gold and mining stuff with gold up. GLTA.

User Image ToRni27 Posted - 1 month ago

$SEOVF But the biggest fraud was the increase in spending. From 6M to 25M. Everyone thought they could operate with 55M for like 4-6 years based on 6M spending per year but that increased to 25M per year. The new CEO will most likely do a new start. Sernova needs more funding like 250M+ anf therefore they need to do a R/S. 100 to 1 to get it back to 33M shares. Get on NASDAQ and raise 250M. Good luck! Any „old“ shareholder will be chapter 11 here.

User Image ToRni27 Posted - 1 month ago

$SEOVF The Evotec investment sucked so many people into this stock. I am sorry for anyone that invested because of the the Evotec investment. The Evotec investment made this look serious.

User Image ToRni27 Posted - 1 month ago

$SEOVF don‘t forget the guy that invested 12 million here from switzerland. Lol all gone! So not only small investors but also those that have a bit more money believed in the story and got frauded. Especially they should have know that human donor cells will not be enough for approval. Thats might be also a reason why Evotec did not do an upfront payment. We needed Evotec more than they needed us.

User Image ToRni27 Posted - 1 month ago

$SEOVF I am warning you 9-11 months now…. Everyone ignored my arguments. 🙈 Evotec cells still not in trials. The earliest they can ask for FDA BLA is 2030… earliest… they need 8 years of funding. They are pre clinical cuz their phase 1/2 human donor cells will not make it to approval cuz of low supply of human donor cells. Former CEO P.T. lied to us but he will say things changed and thats not untrue… forward looking statement.

User Image ToRni27 Posted - 1 month ago

$SEOVF the only good thing is that formers CEO P.T. 3 million shares are worthless too now. I am wondering that we still see zero volume here. Not many jumping ship…. And on the other hand no obe is posting on ST means better to avoid this stock. If no US investor is interested than not enough money coming in to hold SP high over a buck+.

User Image ttesttestt Posted - 1 month ago

$SEOVF mgmt is taking the salary, good salary, but in the end it's only a win for them....

User Image ToRni27 Posted - 1 month ago

$SEOVF Game Over

User Image djahne Posted - 03/27/24

$SEOVF https://www.linkedin.com/posts/joseph-tomecki-49b59a271_im-very-greatful-to-uchicago-medicines-activity-7176772010910314498-RyLi

User Image marvessa Posted - 03/21/24

$SEOVF long term hold , needs patience no doubt

User Image ToRni27 Posted - 2 months ago

$SEOVF CFO got fired… this is a mess.

User Image ToRni27 Posted - 2 months ago

$NVO com’on Novo!! Just buy the trash stock $SEOVF and their awesome diabetes cure in PH 1/2!! Your sub Evotec is already invested. Lets buy them out! Ty.

User Image djahne Posted - 02/29/24

$SEOVF https://youtu.be/Q0ti7H4GfvA?si=h8REMuOw0-wV9GnO

User Image ToRni27 Posted - 02/26/24

$SEOVF speaking today at 1:15 pm EAST.

User Image ToRni27 Posted - 02/20/24

$SEOVF don’t forget that they are searching for new investors. Those normally buy new dilutional shares and not buying at the open market. They need fresh cash.

User Image BriOnH Posted - 3 months ago

@Jdolan99 $VRTX Itolerance, $SEOVF , also some companies in Israel too. Next to $SANA the one that shows the most promise to me is this one: https://www.youtube.com/watch?v=ZUe-A2v8n-I . See where the data takes, will probably gobble up $1-2k over the next year if I like what I see as an opener. Sorry about your sister, highly recommend Loop with $DXCM and $PODD for the best tech in helping manage it.

User Image xMvn020 Posted - 3 months ago

$SEOVF

User Image djahne Posted - 3 months ago

$SEOVF Price Target: 3,80 CAD from First Berlin https://www.more-ir.de/d/28833.pdf

User Image GoodTidings Posted - 01/29/24

$SEOVF If that is true then existing shareholders will definitely be dissapointed and then I describe it very mildly...

User Image marvessa Posted - 01/27/24

$SEOVF a green day 👍

User Image ToRni27 Posted - 01/23/24

$SEOVF yes show us your dilution plan going forward… everything else is well known and nothing new. Evotec phase 1 trails in 2nd half of 2024. Cell coating is work in progress pre clinical. Thxs and bye 😂🤣

User Image djahne Posted - 01/22/24

$SEOVF

User Image djahne Posted - 01/22/24

$SEOVF https://youtu.be/Ss62C2tGz3o?si=h04OxKHAcWKNpucY

Analyst Ratings
Raymond James Market Perform Apr 4, 24